No Access
Industry Watch
https://doi.org/10.1142/S0219030304001508Cited by:0 (Source: Crossref)
Abstract
Trials on Avian Flu Vaccine.
New Corporate Identity for Peplin.
Biota's Improved Performance for FY2003.
Cryptome Receives Funding for Anti-Thrombotic Drug Development.
Genepharm's Aggressive Expansion.
Devil's Apple for Tumor Cells.
China Chain Drug Stores on the Boom.
Hib Vaccine Available in China Market.
New Grade II New Drug: Torasemide.
Indian Pharma Optimistic about Global Market.
Ranbaxy's New Plans for Subsidiaries in Portugal and Canada.
DRL Stock Hit by Massive Pullout.
New Chugai Clinical Research Center.
Keywords:
- Avian Flu Vaccine
- CSIRO Livestock Industries
- Imugene Limited
- H5N1
- Dr Chris Prideaux
- Peplin Biotech Ltd
- Pharmaceuticals for life
- Micheal Aldridge
- Dr Cherrel Hirst
- Biota Holdings Limited
- FLU OIA diagnostics
- GSK
- molecule RSV treatment
- Cryptome
- Anti-Thrombotic Drug Development
- Ian Macfarlane
- CR001
- Generic Pharmaceutical markets
- GAA
- PBS
- distribution agreement
- Spotless Group Ltd
- Devil's Apple
- Tumor Cells
- Drug Stores
- Boom
- Grade II New Drug
- Torasemide
- Hib Vaccine
- haemophilus influenza type b
- Indian Pharma
- Commerce and Industry
- FICCI
- Ranbaxy's New plans
- DRL Stock Hit
- New Chugai Clinical Research center
